Ceria-Based Nanotherapeutics for Inflammatory Skin Disorders: From Design and Mechanisms to Advanced Delivery and Future Perspectives.

Zishang Guo, Wenshang Liu, Fei Pan, Fangwei Guo, Dan Deng

Abstract readReview

In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zishang GuoDepartment of Dermatology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

Wenshang LiuDepartment of Dermatology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

Fei PanDepartment of Health Science and Technology, ETH Zürich, 8092 Zurich, Switzerland.ORCID 0000-0002-9801-5619

Fangwei GuoShanghai Key Laboratory of Advanced High-Temperature Materials and Precision Forming, School of Materials Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.

Dan DengDepartment of Dermatology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

Funding

National Natural Science Foundation of China 52572078National Natural Science Foundation of China 82173396The Clinical Research Plan of SHDC SHDC22025306The Development Project for Innovative Teams of Clinical Subspecialties, Shanghai Children's Medical Center SCMC-XEQ-202603The Scientific Research Program of Shanghai Pudong New Area Health Commision (the Joint Research and Development Program) PW2026D-01

6 · The paper itself

Abstract

Inflammatory skin diseases, including atopic dermatitis (AD), psoriasis, diabetic wounds, and photoaging, represent major public health challenges due to their high prevalence, chronic recurrence, and substantial disease burden. Current treatments, such as glucocorticoids, calcineurin inhibitors, and biologics, are often constrained by limited efficacy, long-term adverse effects, or high costs, highlighting the need for safer and more accessible therapeutic strategies. Cerium oxide nanoparticles (CeO

Indexed as

CeriumNanoparticlesSkin DiseasesAnimalsAnti-Inflammatory AgentsDrug Delivery SystemsHumansNanomedicineAnti-Inflammatory Agentsceric oxideCeriumadvanced delivery strategiescerium oxide nanoparticlesenzyme-mimetic activityinflammatory skin diseasesstructure–activity relationship

Identifiers

PMID42794671

DOI10.3390/ijms27188243

PMCPMC13607874

What Socratic holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.